Botanical guide · Ingredient reference

Schisandra: limited benefit evidence and important tacrolimus interactions

A supervised transplant study is not permission to combine this herb with medicines at home.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What the research addresses

Schisandra is used in traditional formulas for fatigue, liver complaints and other purposes. MSK describes limited human evidence, often involving mixtures or specific treatment settings. Such findings do not establish a general liver-protection or performance benefit from any retail extract. [1]

What the finding does not establish

A laboratory change in liver enzymes is not the same as proving recovery from liver disease. A result for a multi-ingredient formulation also cannot isolate schisandra's contribution. [1]

A monitored interaction is still an interaction

Imagine clinicians deliberately study a preparation that changes a medicine's blood concentration while adjusting doses and monitoring patients. The existence of that study does not mean the combination is safe without monitoring. The protocol and supervision are part of the intervention.

This distinction is easy to lose when an advertisement describes the herb as helping another treatment. Ask what safeguards the study used and what would happen if the same exposure were added to an unchanged medication regimen. A favorable monitored result cannot answer the unsupervised question.

Hypothetical example — illustrates evidence interpretation; not a product or dose recommendation.
Hypothetical finding or choiceWhat it means
Clinicians monitor and adjust a medicineA controlled treatment setting
An herb is added without dose reviewA different interaction risk
Liver enzymes changeNot automatically restored liver health

Safety and treatment considerations

Schisandra can increase tacrolimus blood levels, an effect documented in transplant patients. Other drug-metabolism and transport interactions are also possible. Do not add it to transplant treatment or adjust medication doses independently; specialized monitoring changes the context of a clinical study. [1]

A practical next step

No schisandra product is selected. A pharmacist or treating clinician should assess the exact preparation against the medication list, especially when a medicine's blood levels guide dosing.

Schisandra: limited benefit evidence and important tacrolimus interactions — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Memorial Sloan Kettering Cancer Center — Schisandra
    Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.